Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review.
This article summarizes the literature and collects the opinion of eight experts on the use of fiber-containing enteral formulas in pediatrics.
This article summarizes the literature and collects the opinion of eight experts on the use of fiber-containing enteral formulas in pediatrics.
Caregivers must understand the nature of and indications for specific formulas to treat diseases, provide complete nutrition to patients, and avoid harm.
We briefly describe the history of preterm nutrition, discuss current enteral and parenteral practice, important evidence gaps, a summary of approaches for evaluating nutritional practice, and key considerations for future endeavor. Our discussion refers to all extremely preterm infants and is not confined to the micro-preemie.
In this chapter, we will briefly describe the history of preterm nutrition, discuss current enteral and parenteral practice, important evidence gaps, a summary of approaches for evaluating nutritional practice, and key considerations for future endeavor. Our discussion refers to all extremely preterm infants, not just confined to the micro-preemie.
Several factors should be considered when providing enteral nutrition, including timing and rate of initiation, advancement regimen, feeding modality, and risk of complications.
The aim was to investigate the hypothesis that ingredients of exclusive enteral nutrition formulas are unlikely to initiate a disease flare and that it is not essential for their elimination for disease amelioration.